Prot #NU FC19L02: TH-138: Phase II Randomized Trial of Carboplatin + Pemetrexed + Bevacizumab, with or without Atezolizumab in Stage IV Non-squamous NSCLC Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked

  • Patel, Jyoti D (PD/PI)

Project: Research project

Project Details

Effective start/end date4/21/204/21/23


  • National Comprehensive Cancer Network (Prot #NU FC19L02)
  • Genentech, Inc. (Prot #NU FC19L02)